1,2-Dichloroethane

1,2-Dichloroethane

SCHEMBL504638

CO.ClCCCl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109971539-A A kind of phosphatide and fish oil extracting method for tuna by-product 浙江工商大学 2019-07-05 CN claimed
US-8703895-B2 In-situ method and system for controlling the flow of an organic liquid AQUANEX TECHNOLOGIES, LLC 2014-04-22 US claimed
CN-103232452-A Industrialized semi-synthesis process of vincamine PENG XUEDONG 2013-08-07 CN claimed
CN-102108082-A Industrialized semisynthesis of medicine-vincamine for treating cerebral ischemia GUANGZHOU SWELLXIN SCIENCE AND TECHNOLOGY CO LTD 2011-06-29 CN claimed
CN-101544600-A Method for separating and preparing ricinine FEED RES INST CAAS 2009-09-30 CN claimed
EP-4366691-A1 PROCESS FOR THE PREPARATION OF A PULMONARY SURFACTANT Chiesi Farmaceutici S.p.A. (IT) 2024-05-15 EP disclosed
CN-117447334-A Method for efficiently synthesizing alpha-amino acetal 南京工业大学 2024-01-26 CN disclosed
US-11851415-B2 Continuous isolation of cannabidiol and cannabinoids and conversion of cannabidiol to delta 8-tetrahydrocannabinol and delta 9-tetrahydrocannabinol CLEEN TECHNOLOGY INC. (US) 2023-12-26 US disclosed
US-11851414-B2 Continuous isolation of cannabidiol and conversion of cannabidiol to delta 8-tetrahydrocannabinol and delta 9-tetrahydrocannabinol CLEEN TECHNOLOGY INC. (US) 2023-12-26 US disclosed
EP-3885347-B1 DIHYDROPYRROLOPYRAZOLE DERIVATIVE UBE CORP (JP) 2023-11-22 EP disclosed
WO-2023196629-A1 BENZO[H]QUINAZOLINE-4-AMINE DERIVATIVES FOR THE TREATMENT OF CANCER Redona Therapeutics, Inc. (US) 2023-10-12 WO disclosed
US-11739072-B2 Heteroaryl compounds and their use MINORYX THERAPEUTICS S.L. (ES) 2023-08-29 US disclosed
US-4342711-A EXTRUDING A SPINNING SOLUTION OF POLYMER AND SOLVENT AROUND A STREAM OF SOLVENT AND SWELLING LIQUID; INTO AN AQUEOUS BATH HIGH SPEED NIPPON ZEON CO., LTD. (JP) 1982-08-03 US disclosed
US-4331804-A ANTIBIOTICS ABBOTT LABORATORIES (US) 1982-05-25 US disclosed
US-4326525-A Osmotic device that improves delivery properties of agent in situ ALZA CORPORATION (US) 1982-04-27 US disclosed
US-4284704-A Photographic elements with incorporated hydrogen source photoreductant and tetrazolium salt EASTMAN KODAK COMPANY (US) 1981-08-18 US disclosed
US-4272626-A MULTISTEP FROM 1-EPI-2-DEOXY-2-OXO-TETRA-N-BENZYLOXYCARBONYLFORTIMICIN A VIA THE 2-THIOCARBONYLIMIDAZOLIDE ABBOTT LABORATORIES (US) 1981-06-09 US disclosed
US-4160020-A CELLULOSE ESTERS, CELLULOSE ETHERS ALZA CORPORATION (US) 1979-07-03 US disclosed
US-4155714-A Process and apparatus for conversion of atz to pth amino acid derivatives of proteins HEWLETT-PACKARD COMPANY, 3000 HANOVER ST., PALO ALTO, CA A CORP. OF CA 1979-05-22 US disclosed
US-4137313-A ANTICOAGULANTS, ANTIPHLOGISTIC AGENTS BOEHRINGER INGELHEIM GMBH (DE) 1979-01-30 US disclosed